Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

About this funding opportunity

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

Topic areas: Life Sciences and Health, Education and Training.

Funding amount

This grant provides Up to $500K in funding, up to $500K per award.

Deadline

Applications are due Sep 07, 2026. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• NGOs
• University
• Other
• Public Authorities
• Large Company
• SME

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs); U.S. Territory or Possession.

Agency

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) is administered by National Institutes of Health (NIH), listed via Grants.gov.